Log In
BCIQ
Print this Print this
 

Lytixar (LTX-109)

  Manage Alerts
Collapse Summary General Information
Company Lytix Biopharma A/S
DescriptionTopical synthetic antimicrobial peptidomimetic
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationSkin and skin structure infection (SSSI)
Indication DetailsTreat impetigo
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today